Related references
Note: Only part of the references are listed.Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure
Diana L. Noah et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
Nega Ali Goji et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: A potential priming strategy
I Stephenson et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Probable person-to-person transmission of avian influenza A (H5N1)
K Ungchusak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Avian influenza A (H5N1) in 10 patients in Vietnam.
TT Hien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population
I Stephenson et al.
VACCINE (2003)
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson et al.
LANCET (2001)
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
JJ Treanor et al.
VACCINE (2001)